الابحاث

South Egypt Cancer Institute

Assiut University

Department of Clinical Pathology
# Title Research Member Research Year
31 HLA-B* 15 predicts survival in Egyptian patients with COVID-19 Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2021
32 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
 		Dr. Asmaa Mohamed Zahran Omar 2021
33 Higher CD19+ CD25+ Bregs are independently associated with better graft function in renal transplant recipients Prof. Douaa Mohamed Sayed Hussein 2021
34 Higher CD19+ CD25+ Bregs are independently associated with better graft function in renal transplant recipients Prof. Douaa Mohamed Sayed Hussein 2021
35 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
 		Dr. Asmaa Mohamed Zahran Omar 2021
36 Higher CD19+ CD25+ Bregs are independently associated with better graft function in renal transplant recipients Dr. Iman Hassan Ahmed Hamada 2021
37 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2021
38 Higher CD19+ CD25+ Bregs are independently associated with better graft function in renal transplant recipients Eman Hosny Mohammed Ibrahim 2021
39 Clinical Outcome of Pediatric Acute Myeloid Leukemia Treated at South Egypt Cancer Institute, Assiut University, Egypt Dr. Iman Hassan Ahmed Hamada 2021
40 Monocytic myeloid-derived suppressor cells in chronic lymphocytic leukemia patients: a single center experience Dr. Asmaa Mohamed Zahran Omar 2020